retatrutide triple hormone receptor agonist retatrutide Today, we shared new data from two Phase 3 trials of retatrutide, our investigational agonist. Learn more at our link in bio retatrutide obesity triple hormone receptor

When the inflammatory burden is high from insulin resistance, dyslipidemia (high LDL/triglycerides), high blood pressure, and liver stress it drives cholesterol particles into the artery lining and triggers the plaque buildup that can eventually rupture and cut off blood flow to the heart

Calcium citrate is preferred for GLP-1 users because it does not require stomach acid for absorption, which matters when gastric acid production may be altered

It was originally developed for diabetes and is well-studied

The appetite suppression continues providing therapeutic benefit while the unpleasant gastrointestinal symptoms resolve